The FDA has broadened the indication for Bunavail (buprenorphine and naloxone) buccal film to include induction of buprenorphine treatment for opioid dependence.FDA Approvals (Source: Medscape Psychiatry Headlines)
FDA OKs Bunavail for Induction of Opioid Addiction Treatment FDA OKs Bunavail for Induction of Opioid Addiction Treatment
Next post: U.S. FDA Approves Orexo's Low Dose ZUBSOLV(R) Buprenorphine and Naloxone Sublingual Tablets (CIII)
